Deployment of AI in production is likely to increase over time, due to the development of automated learning processes. Fundamentally, it is likely to boost the competitiveness of the manufacturing sector through efficiency and productivity gains enabled by data analysis, and supply chains would be based on these gains. AI would also boost automation, ensure stronger quality control of products and processes, and preventive diagnostics of machinery status, while also ensuring timely maintenance, near-zero downtime, fewer errors and defective products.
This means that manufacturing processes would be heavily reliant on AI. This would mean that AI would be responsible for drug production or other necessities. For example, if the AI strives for optimisation, it can cut corners and thus, for example, change the composition of drugs. It can also, on its own, take decisions without the persons in charge notice.